Foundations for Success
Premier Client Service
Valuation Research Corporation is a recognized valuation services leader. Learn more about our awards, accolades and accomplishments
Aligned to Objectives
Strength in Values
Valuation Research Corporation is a global provider of tangible and intangible asset valuations.
Knowledge to Lead
Comprehensive Guidance
Valuation Research Corporation’s senior professionals provide guidance to clients with complex valuations.
Global Reach
International Experience
Valuation Research Corporation maintains a respected worldwide presence in more than 20 cities.
Solutions to Complexity
Intricate Knowledge
Valuation Research Corporation provides clients with valuation solutions in line with their business objectives.
We are very pleased with VRC and their level of expertise. They have supported their conclusions effectively with the Board and third parties.
— Keynetics, Inc.

  • VRC completed a fairness opinion for the Infinity Healthcare, Inc. Employee Stock Ownership Plan in connection with its sale to Emcare, Inc., a subsidiary of Envision Healthcare Corporation.
    Fairness Opinion
  • Mu Sigma, Inc. has been recapitalized by its investors. VRC provided a solvency opinion to the Company's board of directors in connection with the transaction.
    Solvency Opinion
  • VRC valued tangible and intangible assets for a purchase price allocation in accordance with ASC 805 for PODS Enterprises, LLC's acquisition of New Age Moving & Storage.
    Allocation of Purchase Price
  • Leonard Green & Partners, L.P. and Ares Management, L.P. have recapitalized the company. VRC provided a solvency opinion to the company's board of directors in connection with the transaction.
    Solvency Opinion
  • AmerisourceBergen has acquired PharMEDium. VRC provided allocation of purchase price in accordance with ASC 805 for the acquisition.
    Allocation of Purchase Price
  • Truco Enterprises (On the Border® retail products) has been recapitalized by Insignia Capital Group. VRC provided a solvency opinion to the Company’s board of directors in connection with the transaction. 4/2016
    Solvency Opinion